Immune-mediated control of Chlamydia infection

Cellular Microbiology

Volumn 10, Issue 1, 2008, Pages 9-19

  Roan, Nadia R ^a   Starnbach, Michael N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL RNA; BACTERIAL VACCINE; BH3 PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CHLAMYDIA VACCINE; DEFENSIN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OUTER MEMBRANE PROTEIN; PROTEASOME; SUBUNIT VACCINE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BLINDNESS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; ECTOPIC PREGNANCY; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INFECTION CONTROL; INFECTION SENSITIVITY; INFERTILITY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REINFECTION; SHORT SURVEY; TH1 CELL; TH2 CELL; TRACHOMA; VACCINATION;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; HUMANS; LYMPHOCYTES;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

EID: 36949034351     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.01069.x     Document Type: Short Survey

References (102)

1. Allen, J.E., Locksley, R.M., and Stephens, R.S. (1991) A single peptide from the major outer membrane protein of Chlamydia trachomatis elicits T cell help for the production of antibodies to protective determinants. J Immunol 147: 674-679.
2. Bannantine, J.P., Griffiths, R.S., Viratyosin, W., Brown, W.J., and Rockey, D.D. (2000) A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol 2: 35-47.
3. Barenfanger, J., and MacDonald, A.B. (1974) The role of immunoglobulin in the neutralization of trachoma infectivity. J Immunol 113: 1607-1617.
4. Barron, A.L., White, H.J., Rank, R.G., Soloff, B.L., and Moses, E.B. (1981) A new animal model for the study of Chlamydia trachomatis genital infections: Infection of mice with the agent of mouse pneumonitis. J Infect Dis 143: 63-66.
5. Beatty, P.R., and Stephens, R.S. (1992) Identification of Chlamydia trachomatis antigens by use of murine T-cell lines. Infect Immun 60: 4598-4603.
6. Beatty, W.L., Byrne, G.I., and Morrison, R.P. (1993) Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 90: 3998-4002.
7. Bernstein-Hanley, I., Coers, J., Balsara, Z.R., Taylor, G.A., Starnbach, M.N., and Dietrich, W.F. (2006) The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci USA 103: 14092-14097.
8. Brunham, R.C., and Rey-Ladino, J. (2005) Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5: 149-161.
9. Buchholz, K.R., and Stephens, R.S. (2006) Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis. Cell Microbiol 8: 1768-1779.
10. Byrd, T.F., and Horwitz, M.A. (1993) Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest 91: 969-976.
11. Byrne, G.I., and Ojcius, D.M. (2004) Chlamydia and apoptosis: Life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2: 802-808.
12. Caldwell, H.D., Kromhout, J., and Schachter, J. (1981) Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31: 1161-1176.
13. Chen, B., Stout, R., and Campbell, W.F. (1996) Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells. FEMS Immunol Med Microbiol 14: 109-120.
14. Clifton, D.R., Fields, K.A., Grieshaber, S.S., Dooley, C.A., Fischer, E.R., Mead, D.J., et al. (2004) A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA 101: 10166-10171.
15. Coles, A.M., Reynolds, D.J., Harper, A., Devitt, A., and Pearce, J.H. (1993) Low-nutrient induction of abnormal chlamydial development: A novel component of chlamydial pathogenesis? FEMS Microbiol Lett 106: 193-200.
16. Cotter, T.W., Meng, Q., Shen, Z.L., Zhang, Y.X., Su, H., and Caldwell, H.D. (1995) Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 63: 4704-4714.
17. Cotter, T.W., Ramsey, K.H., Miranpuri, G.S., Poulsen, C.E., and Byrne, G.I. (1997a) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 65: 2145-2152.
18. Cotter, T.W., Miranpuri, G.S., Ramsey, K.H., Poulsen, C.E., and Byrne, G.I. (1997b) Reactivation of chlamydial genital tract infection in mice. Infect Immun 65: 2067-2073.
19. Cresswell, P., Ackerman, A.L., Giodini, A., Peaper, D.R., and Wearsch, P.A. (2005) Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 207: 145-157.
20. Darville, T., O'Neill, J.M., Andrews, C.W., Jr, Nagarajan, U.M., Stahl, L., and Ojcius, D.M. (2003) Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 171: 6187-6197.
21. Dessus-Babus, S., Darville, T.L., Cuozzo, F.P., Ferguson, K., and Wyrick, P.B. (2002) Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis. Infect Immun 70: 3234-3248.
22. Everett, K.D., Bush, R.M., and Andersen, A.A. (1999) Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 49 (Pt 2): 415-440.
23. + T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci USA 98: 1160-1165.
24. Freidank, H.M., Billing, H., and Wiedmann-Al-Ahmad, M. (2001) Influence of iron restriction on Chlamydia pneumoniae and C.trachomatis. J Med Microbiol 50: 223-227.
25. Gaczynska, M., Rock, K.L., and Goldberg, A.L. (1993) Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365: 264-267.
26. Gerard, H.C., Branigan, P.J., Schumacher, H.R., Jr, and Hudson, A.P. (1998) Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25: 734-742.
27. Grayston, J.T., and Wang, S. (1975) New knowledge of chlamydiae and the diseases they cause. J Infect Dis 132: 87-105.
28. Grayston, J.T., and Wang, S.P. (1978) The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 5: 73-77.
29. Gupta, S.L., Carlin, J.M., Pyati, P., Dai, W., Pfefferkorn, E.R., and Murphy, M.J., Jr. (1994) Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect Immun 62: 2277-2284.
30. Hawkins, R.A., Rank, R.G., and Kelly, K.A. (2002) A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa. Infect Immun 70: 5132-5139.
31. Hogan, R.J., Mathews, S.A., Mukhopadhyay, S., Summersgill, J.T., and Timms, P. (2004) Chlamydial persistence: Beyond the biphasic paradigm. Infect Immun 72: 1843-1855.
32. Hook, C.E., Telyatnikova, N., Goodall, J.C., Braud, V.M., Carmichael, A.J., Wills, M.R., and Gaston, J.S. (2004) Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis. Clin Exp Immunol 138: 54-60.
33. Igietseme, J.U., Ramsey, K.H., Magee, D.M., Williams, D.M., Kincy, T.J., and Rank, R.G. (1993) Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol 5: 317-324.
34. + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun 62: 5195-5197.
35. Igietseme, J.U., Uriri, I.M., Chow, M., Abe, E., and Rank, R.G. (1997) Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem Biophys Res Commun 232: 595-601.
36. Ishizaki, M., Allen, J.E., Beatty, P.R., and Stephens, R.S. (1992) Immune specificity of murine T-cell lines to the major outer membrane protein of Chlamydia trachomatis. Infect Immun 60: 3714-3718.
37. Ito, J.I., and Lyons, J.M. (1999) Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun 67: 5518-5521.
38. Jawetz, E., Rose, L., Hanna, L., and Thygeson, P. (1965) Experimental inclusion conjunctivitis in man: Measurements of infectivity and resistance. JAMA 194: 620-632.
39. Jendro, M.C., Fingerle, F., Deutsch, T., Liese, A., Kohler, L., Kuipers, J.G., et al. (2004) Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-alpha in vitro. Med Microbiol Immunol 193: 45-52.
40. Johansson, M., and Lycke, N. (2001) Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells. Immunology 102: 199-208.
41. Johansson, M., Schon, K., Ward, M., and Lycke, N. (1997) Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun 65: 1032-1044.
42. Johnson, R.M. (2004) Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun 72: 3951-3960.
43. Joyee, A.G., Qiu, H., Wang, S., Fan, Y., Bilenki, L., and Yang, X. (2007) Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J Immunol 178: 1048-1058.
44. Lampe, M.F., Wilson, C.B., Bevan, M.J., and Starnbach, M.N. (1998) Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 66: 5457-5461.
45. Landers, D.V., Erlich, K., Sung, M., and Schachter, J. (1991) Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis. Infect Immun 59: 3774-3777.
46. + T cells. J Immunol 177: 4021-4027.
47. McSorley, S.J., Asch, S., Costalonga, M., Reinhardt, R.L., and Jenkins, M.K. (2002) Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 16: 365-377.
48. Magee, D.M., Igietseme, J.U., Smith, J.G., Bleicker, C.A., Grubbs, B.G., Schachter, J., et al. (1993) Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse. Reg Immunol 5: 305-311.
49. Magee, D.M., Williams, D.M., Smith, J.G., Bleicker, C.A., Grubbs, B.G., Schachter, J., and Rank, R.G. (1995) Role of CD8 T cells in primary Chlamydia infection. Infect Immun 63: 516-521.
50. de la Maza, L.M., and Peterson, E.M. (2002) Vaccines for Chlamydia trachomatis infections. Curr Opin Investig Drugs 3: 980-986.
51. Misaghi, S., Balsara, Z.R., Catic, A., Spooner, E., Ploegh, H.L., and Starnbach, M.N. (2006) Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 61: 142-150.
52. Miyairi, I., and Byrne, G.I. (2006) Chlamydia and programmed cell death. Curr Opin Microbiol 9: 102-108.
53. Moore, T., Ananaba, G.A., Bolier, J., Bowers, S., Belay, T., Eko, F.O., and Igietseme, J.U. (2002) Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105: 213-221.
54. Moore, T., Ekworomadu, C.O., Eko, F.O., MacMillan, L., Ramey, K., Ananaba, G.A., et al. (2003) Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 188: 617-624.
55. Morrison, R.P., Feilzer, K., and Tumas, D.B. (1995) Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 63: 4661-4668.
56. +) T cells. Infect Immun 68: 6979-6987.
57. Morrison, S.G., and Morrison, R.P. (2005) A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 175: 7536-7542.
58. Moulder, J.W. (1991) Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55: 143-190.
59. Murphey, C., Murthy, A.K., Meier, P.A., Neal Guentzel, M., Zhong, G., and Arulanandam, B.P. (2006) The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell Immunol 242: 110-117.
60. Nelson, D.E., Virok, D.P., Wood, H., Roshick, C., Johnson, R.M., Whitmire, W.M., et al. (2005) Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci USA 102: 10658-10663.
61. O'Connell, C.M., Ionova, I.A., Quayle, A.J., Visintin, A., and Ingalls, R.R. (2006) Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol Chem 281: 1652-1659.
62. Pal, S., Theodor, I., Peterson, E.M., and de la Maza, L.M. (2001) Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge. Infect Immun 69: 6240-6247.
63. Parr, M.B., and Parr, E.L. (1990) Antigen recognition in the female reproductive tract. I. Uptake of intraluminal protein tracers in the mouse vagina. J Reprod Immunol 17: 101-114.
64. Parr, M.B., and Parr, E.L. (1991) Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol Reprod 44: 491-498.
65. Patton, D.L., Askienazy-Elbhar, M., Henry-Suchet, J., Campbell, L.A., Cappuccio, A., Tannous, W., et al. (1994) Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 171: 95-101.
66. Peeling, R., Maclean, I.W., and Brunham, R.C. (1984) In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein. Infect Immun 46: 484-488.
67. Perfettini, J.L., Darville, T., Gachelin, G., Souque, P., Huerre, M., Dautry-Varsat, A., and Ojcius, D.M. (2000) Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract. Infect Immun 68: 2237-2244.
68. Perry, L.L., Feilzer, K., and Caldwell, H.D. (1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 158: 3344-3352.
69. Perry, L.L., Feilzer, K., Portis, J.L., and Caldwell, H.D. (1998) Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J Immunol 160: 2905-2914.
70. Peterson, E.M., Cheng, X., Markoff, B.A., Fielder, T.J., and de la Maza, L.M. (1991) Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies. Infect Immun 59: 4147-4153.
71. Pirbhai, M., Dong, F., Zhong, Y., Pan, K.Z., and Zhong, G. (2006) The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem 281: 31495-31501.
72. Porter, E., Yang, H., Yavagal, S., Preza, G.C., Murillo, O., Lima, H., et al. (2005) Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 73: 4823-4833.
73. Prebeck, S., Brade, H., Kirschning, C.J., da Costa, C.P., Durr, S., Wagner, H., and Miethke, T. (2003) The Gram-negative bacterium Chlamydia trachomatis L2 stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin. Microbes Infect 5: 463-470.
74. Quayle, A.J. (2002) The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 57: 61-79.
75. Rahman, M.U., Cheema, M.A., Schumacher, H.R., and Hudson, A.P. (1992) Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 35: 521-529.
76. Ramsey, K.H., and Rank, R.G. (1991) Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 59: 925-931.
77. Ramsey, K.H., Cotter, T.W., Salyer, R.D., Miranpuri, G.S., Yanez, M.A., Poulsen, C.E., et al. (1999) Prior genital tract infection with a murine or human biovar of Chlamydiatrachomatis protects mice against heterotypic challenge infection. Infect Immun 67: 3019-3025.
78. Rank, R.G., Soderberg, L.S., and Barron, A.L. (1985) Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun 48: 847-849.
79. Rasmussen, S.J., Eckmann, L., Quayle, A.J., Shen, L., Zhang, Y.X., Anderson, D.J., et al. (1997) Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 99: 77-87.
80. Raulston, J.E. (1997) Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 65: 4539-4547.
81. + T cells respond to Chlamydia trachomatis in the genital mucosa. J Immunol 177: 7974-7979.
82. Roan, N.R., Gierahn, T.M., Higgins, D.E., and Starnbach, M.N. (2006) Monitoring the T cell response to genital tract infection. Proc Natl Acad Sci USA 103: 12069-12074.
83. Rott, L.S., Briskin, M.J., Andrew, D.P., Berg, E.L., and Butcher, E.C. (1996) A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation. J Immunol 156: 3727-3736.
84. Rottenberg, M.E., Gigliotti-Rothfuchs, A., and Wigzell, H. (2002) The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol 14: 444-451.
85. Stagg, A.J. (1998) Vaccines against Chlamydia: Approaches and progress. Mol Med Today 4: 166-173.
86. Starnbach, M.N., Bevan, M.J., and Lampe, M.F. (1994) Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 153: 5183-5189.
87. + T cell response. J Immunol 171: 4742-4749.
88. + T cell response. J Immunol 173: 6327-6337.
89. Steimle, V., Siegrist, C.A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265: 106-109.
90. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun 63: 3302-3308.
91. Su, H., Morrison, R.P., Watkins, N.G., and Caldwell, H.D. (1990) Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med 172: 203-212.
92. Su, H., Feilzer, K., Caldwell, H.D., and Morrison, R.P. (1997) Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 65: 1993-1999.
93. + cells. Med Microbiol Immunol (Berl) 187: 71-78.
94. Trombetta, E.S., and Mellman, I. (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23: 975-1028.
95. Tuffrey, M., Falder, P., Gale, J., and Taylor-Robinson, D. (1986) Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br J Exp Pathol 67: 605-616.
96. Wang, S.P., Grayston, J.T., and Gale, J.L. (1973) Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol 110: 873-879.
97. Williams, D.M., Grubbs, B.G., Pack, E., Kelly, K., and Rank, R.G. (1997) Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect Immun 65: 2876-2882.
98. World Health Organization (2001) Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization.
99. Zhong, G.M., and de la Maza, L.M. (1988) Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1. Infect Immun 56: 3322-3325.
100. Zhong, G., Fan, T., and Liu, L. (1999) Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med 189: 1931-1938.
101. Zhong, G., Liu, L., Fan, T., Fan, P., and Ji, H. (2000) Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J Exp Med 191: 1525-1534.
102. Zhong, G., Fan, P., Ji, H., Dong, F., and Huang, Y. (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942.